Foster City, CA, United States of America

Lan Jiang

USPTO Granted Patents = 64 (Patent Applications = 21)

CIPO Patents = 5 (Patent Applications = 9)

EPO Patents = 17 (Patent Applications = 20)

Average Co-Inventor Count = 6.4

ph-index = 12

Forward Citations = 433(Granted Patents)

Forward Citations (Not Self Cited) = 261(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Fjoster City, CA (US) (2014)
South San Francisco, CA (US) (2021)
Foster City, CA (US) (2008 - 2024)

Company Filing History:

22 out of 262

Theravance Biopharma R&d Ip, LLC

Gilead Sciences, Inc.

patents

4. 7 out of 15

Pliant Therapeutics, Inc.

patents

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Bridged Tricyclic Carbamoylpyridone Compounds

MCL1 Inhibitors

Substituted Pyridotriazine Compounds

JAK Kinase Inhibitors

Amino Acid Compounds

8-Azabicyclo[3.2.1]Octane Compounds

Hepatitis C Virus Inhibitors

Fused Imidazo-Piperidine Compounds

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2025-09-23),

2. RE50554 - Amino acid compounds and methods of use (2025-08-26),

3. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2025-02-18),

4. 12202842 - MCL1 inhibitors (2025-01-21),

5. 12187734 - Substituted pyridotriazine compounds and uses thereof (2025-01-07),

6. 12162844 - MCL-1 inhibitors (2024-12-10),

7. 12122776 - Tetracyclic compounds and uses thereof (2024-10-22),

8. 12054496 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-08-06),

9. 12024528 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-07-02),

10. 11897892 - Substituted pyridotriazine compounds and uses thereof (2024-02-13),

11. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease (2023-08-08),

12. 11697652 - Tetracyclic compounds and uses thereof (2023-07-11),

13. 11673887 - N-acyl amino acid compounds and methods of use (2023-06-13),

14. 11667652 - MCL1 inhibitors (2023-06-06),

15. 11643400 - MCL-1 inhibitors (2023-05-09),

Title: The Innovative Journey of Lan Jiang

Introduction: Lan Jiang, a pioneering inventor based in Foster City, CA, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Lan Jiang's most recent patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary blockchain technology for secure data management, and an innovative renewable energy system for sustainable power generation.

Career Highlights: Lan Jiang's illustrious career is marked by her role as the lead inventor at a renowned tech company, where she spearheaded the development of next-generation software solutions. Her expertise in machine learning and data science has led to the creation of several award-winning products that have transformed industries.

Collaborations: Lan Jiang has collaborated with top research institutions and universities to further her innovative projects. Her partnerships with leading experts in the field have resulted in the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: Lan Jiang's passion for innovation and her relentless pursuit of excellence have established her as a trailblazer in the world of technology. Her inventive spirit continues to inspire the next generation of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.